These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 12457179)
1. Crowd control in the crypt. Booth C; Brady G; Potten CS Nat Med; 2002 Dec; 8(12):1360-1. PubMed ID: 12457179 [No Abstract] [Full Text] [Related]
2. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869 [TBL] [Abstract][Full Text] [Related]
3. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Liu W; Dong X; Mai M; Seelan RS; Taniguchi K; Krishnadath KK; Halling KC; Cunningham JM; Boardman LA; Qian C; Christensen E; Schmidt SS; Roche PC; Smith DI; Thibodeau SN Nat Genet; 2000 Oct; 26(2):146-7. PubMed ID: 11017067 [No Abstract] [Full Text] [Related]
5. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Andreu P; Colnot S; Godard C; Gad S; Chafey P; Niwa-Kawakita M; Laurent-Puig P; Kahn A; Robine S; Perret C; Romagnolo B Development; 2005 Mar; 132(6):1443-51. PubMed ID: 15716339 [TBL] [Abstract][Full Text] [Related]
6. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Hu MC; Rosenblum ND Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399 [TBL] [Abstract][Full Text] [Related]
7. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis. Bhatia N; Spiegelman VS Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534 [TBL] [Abstract][Full Text] [Related]
8. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598 [TBL] [Abstract][Full Text] [Related]
9. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729 [TBL] [Abstract][Full Text] [Related]
10. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908 [TBL] [Abstract][Full Text] [Related]
11. Linking pathways in colorectal cancer. van den Brink GR Nat Genet; 2004 Oct; 36(10):1038-9. PubMed ID: 15454939 [No Abstract] [Full Text] [Related]
12. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054 [TBL] [Abstract][Full Text] [Related]
13. Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Yamada Y; Mori H Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742 [TBL] [Abstract][Full Text] [Related]
14. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
15. [beta-catenin overexpression in metastasized colorectal carcinoma--an important mechanism in progression of the disease?]. Mann B; Gratchev A; Riede E; Schmidt-Wolf I; Trojanek B; Moyer P; Hanski C; Buhr HJ Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):303-6. PubMed ID: 14518265 [TBL] [Abstract][Full Text] [Related]
16. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100 [TBL] [Abstract][Full Text] [Related]
17. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320 [TBL] [Abstract][Full Text] [Related]
18. Identification of Tcf-4 as a transcriptional target of p53 signalling. Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988 [TBL] [Abstract][Full Text] [Related]
20. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]